TANDEM DIABETES CARE INC TNDM
ASignal's systematic analysis rates TNDM as Neutral.
Reflects the latest available analysis · analyzed Sep 25, 2026
The case on TNDM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- RSI indicates oversold conditions (21.41)
- Price near Bollinger Lower Band (14.58) suggesting potential reversal
- Gross margin of 56.01% indicates pricing power
- Current ratio of 3.18x and quick ratio of 2.44x reflect strong liquidity
- MACD below signal line with negative histogram (-0.369), indicating bearish momentum
- Negative price momentum (-0.169) and trading below both SMA20 and SMA50
- Negative operating cash flow (-$5.52M) and free cash flow (-$43.95M)
- High debt-to-equity ratio (5.67x) and negative return on equity (-48.03%)
- Forward P/E of 90.76x suggests high valuation relative to earnings
- Low news and Reddit engagement (10 mentions each), indicating limited market interest
See the full verdict on TNDM
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes TNDM
Most investors never get a second opinion, let alone several. ASignal runs TNDM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.